Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on Teradyne, Lowers Price Target to $120

Keybanc analyst Steve Barger maintains Teradyne (NASDAQ:TER) with a Overweight and lowers the price target from $140 to $120.
byBenzinga Newsdesk
July 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Keybanc analyst Steve Barger maintains Teradyne (NASDAQ:TER) with a Overweight and lowers the price target from $140 to $120.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts